Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29867522 | 1.00 | DRD1 (0.64) | DRD1 | |
| SCHEMBL21374252 | 0.82 | DRD1 (0.62) | DRD1 | |
| SCHEMBL30066813 | 0.82 | DRD1 (0.62) | DRD1 | |
| SCHEMBL15871415 | 0.82 | DRD1 (0.62) | DRD1 | |
| SCHEMBL13412868 | 0.80 | DRD1 (0.73) | DRD1 | |
| SCHEMBL29589463 | 0.79 | DRD1 (0.58) | DRD1 | |
| SCHEMBL709870 | 0.79 | DRD1 (0.58) | DRD1 | |
| SCHEMBL29883736 | 0.79 | DRD1 (0.58) | DRD1 | |
| SCHEMBL29867917 | 0.79 | DRD1 (0.58) | DRD1 | |
| SCHEMBL1315091 | 0.79 | DRD1 (0.58) | DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4320092-A1 | METHYLCYCLOHEXANE AS ALLYL ALCOHOL HYDROFORMYLATION SOLVENT | Lyondell Chemical Technology, L.P. (US) | 2024-02-14 | — | — | EP | claimed |
| US-11613510-B2 | Methylcyclohexane as allyl alcohol hydroformylation solvent | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2023-03-28 | — | — | US | claimed |
| US-20220324782-A1 | METHYLCYCLOHEXANE AS ALLYL ALCOHOL HYDROFORMYLATION SOLVENT | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2022-10-13 | — | — | US | claimed |
| US-7612241-B1 | Hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2009-11-03 | — | — | US | claimed |
| EP-4320092-A1 | METHYLCYCLOHEXANE AS ALLYL ALCOHOL HYDROFORMYLATION SOLVENT | Lyondell Chemical Technology, L.P. (US) | 2024-02-14 | — | — | EP | disclosed |
| US-11613510-B2 | Methylcyclohexane as allyl alcohol hydroformylation solvent | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2023-03-28 | — | — | US | disclosed |
| WO-2022216938-A1 | METHYLCYCLOHEXANE AS ALLYL ALCOHOL HYDROFORMYLATION SOLVENT | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2022-10-13 | — | — | WO | disclosed |
| US-20220324782-A1 | METHYLCYCLOHEXANE AS ALLYL ALCOHOL HYDROFORMYLATION SOLVENT | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2022-10-13 | — | — | US | disclosed |
| US-8124805-B2 | Allyl acetate hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2012-02-28 | — | — | US | disclosed |
| US-20110124904-A1 | Allyl acetate hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. | 2011-05-26 | — | — | US | disclosed |
| US-7612241-B1 | Hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2009-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11613510-B2 | Methylcyclohexane as allyl alcohol hydroformylation solvent | ADH1C, ADH5, ADH1A | DRD1 293/4885 |
| US-20110124904-A1 | Allyl acetate hydroformylation process | GNPAT, DHPS, ALDH3A1 | DRD1 2526/4885 |
| US-20220324782-A1 | METHYLCYCLOHEXANE AS ALLYL ALCOHOL HYDROFORMYLATION SOLVENT | ADH1C, ADH5, ADH1A | DRD1 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.